Here's the live share price of Aspira Pathlab & Diagnostics along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Aspira Pathlab & Diagnostics has gained 21.18% CAGR. Over the past year, the corresponding return has been 14.15%.
Aspira Pathlab & Diagnostics’s current P/E of 25.98x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Aspira Pathlab & Diagnostics | -5.95 | -11.38 | -8.33 | -5.88 | 14.15 | 12.94 | 21.18 |
| Max Healthcare Institute | -3.10 | 3.14 | -7.75 | 5.22 | 12.87 | 36.03 | 60.71 |
| Apollo Hospitals Enterprise | -1.99 | 3.19 | 2.47 | 10.40 | 9.38 | 19.34 | 29.97 |
| Fortis Healthcare | -1.14 | 3.59 | 19.54 | 51.19 | 63.71 | 54.64 | 51.62 |
| Narayana Hrudayalaya | 1.30 | 1.26 | -8.41 | -0.30 | 37.93 | 30.44 | 39.83 |
| Global Health | -2.46 | 0.59 | 0.24 | 9.17 | 18.85 | 46.77 | 25.88 |
| Aster DM Healthcare | -4.05 | 7.46 | 12.03 | 33.17 | 52.61 | 39.94 | 38.27 |
| Krishna Institute of Medical Sciences | 0.51 | 5.28 | -3.57 | 9.77 | 32.88 | 34.50 | 29.43 |
| Dr. Lal Pathlabs | 3.01 | -0.95 | -0.43 | 12.12 | 0.80 | 6.93 | 6.70 |
| Dr. Agarwals Health Care | -0.87 | 2.48 | 12.87 | 46.28 | 28.66 | 8.76 | 5.17 |
| Rainbow Childrens Medicare | 0.27 | 1.81 | -10.17 | 0.61 | -15.08 | 25.72 | 24.92 |
| Healthcare Global Enterprises | -1.23 | 15.21 | 20.42 | 30.85 | 66.59 | 37.56 | 44.23 |
| Jupiter Life Line Hospitals | 4.97 | 5.89 | 10.75 | 8.69 | 17.74 | 13.83 | 8.08 |
| Metropolis Healthcare | 3.42 | -3.13 | -1.07 | 16.81 | -7.88 | 5.33 | 0.24 |
| Vijaya Diagnostic Centre | 0.12 | -1.26 | -7.98 | -0.87 | -0.71 | 31.33 | 9.84 |
| Yatharth Hospital & Trauma Care Services | -0.03 | 6.39 | 23.62 | 69.30 | 20.94 | 33.72 | 19.05 |
| Thyrocare Technologies | 10.37 | 21.57 | 5.43 | 55.98 | 48.91 | 29.60 | 3.96 |
| Kovai Medical Center and Hospital | -4.26 | 2.32 | 2.44 | 20.49 | 17.24 | 62.34 | 55.22 |
| Indraprastha Medical Corporation | 10.95 | 32.45 | 28.41 | 53.20 | 48.12 | 104.27 | 65.46 |
| Artemis Medicare Services | 1.31 | 5.71 | 3.89 | -4.78 | -10.88 | 51.58 | 72.07 |
Over the last one year, Aspira Pathlab & Diagnostics has gained 14.15% compared to peers like Max Healthcare Institute (12.87%), Apollo Hospitals Enterprise (9.38%), Fortis Healthcare (63.71%). From a 5 year perspective, Aspira Pathlab & Diagnostics has underperformed peers relative to Max Healthcare Institute (60.71%) and Apollo Hospitals Enterprise (29.97%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 64.04 | 63.31 |
| 10 | 64.77 | 63.76 |
| 20 | 64.86 | 64.01 |
| 50 | 63.63 | 63.5 |
| 100 | 61 | 62.98 |
| 200 | 66.02 | 61.5 |
In the latest quarter, Aspira Pathlab & Diagnostics remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved down to 81.61% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Oct 14, 2025, 12:58 AM IST | Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Open Offer - Updates |
| Oct 14, 2025, 12:14 AM IST | Aspira Pathlab & Dia - Draft Letter of Offer |
| Oct 07, 2025, 11:46 PM IST | Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 06, 2025, 11:09 PM IST | Aspira Pathlab & Dia - Disclosure Regarding Detailed Public Statement ("DPS") In Relation To The Open Offer To The Public Sha |
| Oct 06, 2025, 8:06 PM IST | Aspira Pathlab & Dia - Detailed Public Statement |
Aspira Pathlab & Diagnostics Ltd. is a Public Limited Listed company incorporated on 03/07/1973 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L85100MH1973PLC289209 and registration number is 289209. Currently Company is involved in the business activities of Other human health activities. Company's Total Operating Revenue is Rs. 22.00 Cr. and Equity Capital is Rs. 10.29 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Aspira Pathlab & Diagnostics is ₹60.50 as on Oct 31, 2025.
The Aspira Pathlab & Diagnostics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Aspira Pathlab & Diagnostics is ₹62.27 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Aspira Pathlab & Diagnostics are ₹62.50 and ₹60.47.
The 52-week high/low is the highest and lowest price at which Aspira Pathlab & Diagnostics stock has traded in the past 52-week or nearly a year. The 52-week high of Aspira Pathlab & Diagnostics is ₹106.78 and 52-week low of Aspira Pathlab & Diagnostics is ₹50.49 as on Oct 31, 2025.
The Aspira Pathlab & Diagnostics has shown returns of -3.97% over the past day, -11.38% for the past month, -8.33% over 3 months, 14.15% over 1 year, 12.94% across 3 years, and 21.18% over 5 years.
P/E ratio of and PB ratio of Aspira Pathlab & Diagnostics are 25.98 and 5.12 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.